“Two-phase”的搜索结果，显示 341-350 项，共有 7518 项

1. 血液科- 临床试验- 妙佑医疗国际

   The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety ... 2, a protein needed for cancer cell survival. Giving venetoclax ... A Study to Test the Effectiveness of Two ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

6. 血液科- 临床试验- 妙佑医疗国际

   The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study includes 2 parts; step-up dose optimization (Part 1) and dose ... This phase 1b trial is an open-label study designed to assess the safety ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 ...